Welcome to our NDD Community
A resource centre for healthcare professionals working in neurodevelopmental disorders such as Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder, and learning disabilities
Attention Deficit Hyperactivity Disorder (ADHD): Flynn has been directly involved in the field of ADHD for over ten years. During this time we have sought to raise awareness of the condition and its impact on the individual, with the aim of bringing about positive change to those whose lives are affected by the diagnosis.
Smith-Magenis Syndrome (SMS): Flynn has collaborated with clinicians and leaders working within the NHS and elsewhere to create a range of healthcare professional and patient-focussed resources to support the patient journey.
Latest Events
Featured Event
Sleep in Children with Neurogenetic Disorders: Improving Outcomes for Families
Sleep in Children with Neurogenetic Disorders: Improving Outcomes for Families
Become an NDD Community Member
Join our community as a Member and keep up to date on the latest developments.
Latest Education and Training
Slenyto (prolonged-release melatonin) Treatment Algorithm
This treatment decision algorithm allows healthcare professionals to personalise titration of Slenyto to optimal dose.
Treatment success is attained by achieving one or more of the following:
Information for Parents of Children Prescribed Meflynate® XL (Methylphenidate Hydrochloride)
Information for parents of children prescribed Meflynate XL - a general guide to treatment with Meflynate XL.
Slenyto® (Prolonged release melatonin) Placebo Dose Card
A paediatric dose card illustrating the range of presentations for Slenyto®
To request this material please contact us.
Request a meeting
Send a virtual meeting request
'ART' - The ADHD Referral Toolkit
‘ART’ – the ADHD Referral Toolkit - is a primary care toolkit designed to improve the quality of ADHD referrals to secondary care. This resource is available to all UK primary care clinicians. In this video Dr Jeremy Mudunkotuwe, Consultant Psychiatrist, Surrey and Borders NHS Foundation Trust and Dr Nina Champaneri, Consultant Child and Adolescent Psychiatrist, in the Forward-Thinking Birmingham Crisis and Home Treatment Team provide information on the tool’s availability and its applicability for primary care.
ART is a bespoke EMIS and SystmOne protocol which helps primary care clinicians to:
- assess patients who present with the symptoms of ADHD
- decide if the patient should be referred for further assessment by a specialist
- generate a referral letter by automatically collating key information into a letter template
This video gives an overview of the referral toolkit and outlines the benefits of it to both the NHS and the patient.
ART is provided as a service to medicine by Flynn Pharma Ltd.
